Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             118 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Allogeneic hematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome: 2023 update of the Milan experience Onida, Francesco

190 S1 p.
artikel
2 Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study De Masson, Adele

190 S1 p.
artikel
3 Analysis of clonal immunoglobulin chain gene rearrangement by the technique of polymerase chain reaction (PCR) to aid in the diagnosis of B-cell cutaneous lymphoproliferative processes Guimaraes, Adriana Borba

190 S1 p.
artikel
4 Annual Meeting
190 S1 p.
artikel
5 Annual Meeting Sponsor Page
190 S1 p.
artikel
6 A novel inducible knockout mouse strain to study the impact of one-copy loss of HNRNPK in CD4 T cells as an experimental model of cutaneous lymphoma Luo, Yixin

190 S1 p.
artikel
7 An overview of the epidemiology and therapeutical modalities in 426 patients with mycosis fungoides and folliculotropic mycosis fungoides in the Netherlands: a retrospective cohort study Kersten, Juliette

190 S1 p.
artikel
8 Anti-PD-L1 and lenalidomide enhance anti-tumor immunity in cutaneous T cell lymphoma through targeting PD1+M2-like tumor-associated macrophages Querfeld, Christiane

190 S1 p.
artikel
9 A real-world international observational study of mogamulizumab in adult patients with mycosis fungoides and Sézary syndrome (PROSPER study NCT05455931) Scarisbrick, Julia

190 S1 p.
artikel
10 Author Index
190 S1 p.
artikel
11 Black patients with cutaneous T-cell lymphomas have inferior outcomes: an analysis of the National Cancer Database from 2004–2019 Allen, Pamela

190 S1 p.
artikel
12 Blood tumour burden does not correlate with skin tumour burden in early-stage mycosis fungoides (MF): PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) registry analysis Charalambides, Maria

190 S1 p.
artikel
13 Brentuximab vedotin as a bridging treatment for mycosis fungoides prior to reduced intensity allogeneic stem cell transplant Sim, Van

190 S1 p.
artikel
14 Capturing the patient’s voice in cutaneous lymphoma Lawrance, Nicholas

190 S1 p.
artikel
15 CCR8 expression as a potential diagnostic and therapeutic biomarker in cutaneous T-cell lymphoma Geller, Shamir

190 S1 p.
artikel
16 CD8 positive Sézary syndrome: two cases Peterknecht, Elizabeth

190 S1 p.
artikel
17 CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas Ta, Van Anh

190 S1 p.
artikel
18 Characterization of skin barrier function and ceramide composition in patients with mycosis fungoides Mergen, Catherine

190 S1 p.
artikel
19 Chlormethine gel as first-line and as maintenance treatment in MF stages IA–IIB Koumourtzis, Marios

190 S1 p.
artikel
20 Chlormethine gel as maintenance treatment for patients with mycosis fungoides Geskin, Larisa

190 S1 p.
artikel
21 Chlormethine gel in combination with retinoids for treatment of mycosis fungoides Teoli, Miriam

190 S1 p.
artikel
22 Chlormethine gel is an effective “add-on” agent for the treatment of skin lesions in patients with mycosis fungoides in clinical practice Morsia, Erika

190 S1 p.
artikel
23 Clinical presentation and treatment outcome in two patients with intravascular large B cell lymphoma Osmancevic, Amra

190 S1 p.
artikel
24 Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: a systematic review Roccuzzo, Gabriele

190 S1 p.
artikel
25 Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1+ epithelial-type γδT cells Nakagawa, Yuki

190 S1 p.
artikel
26 Combination of JAKi and HDACi as a potential anti-angiogenic treatment in a cutaneous T-cell lymphoma (CTCL) in vivo chick embryo model Karagianni, Fani

190 S1 p.
artikel
27 Concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam therapy in 14 patients with tumor stage mycosis fungoides Oymanns, Mathias

190 S1 p.
artikel
28 Concurrent TSEBT and systemic therapies in advanced CTCL: our practical approach in Krefeld, Germany Oymanns, Mathias

190 S1 p.
artikel
29 Copyright Page
190 S1 p.
artikel
30 Cutaneous lymphoproliferations after mRNA vaccination: a clinicopathologic characterization Kempf, Werner

190 S1 p.
artikel
31 Cutaneous manifestation of mature plasmacytoid dendritic cell proliferation in patients with myeloid leukemia Hillen, Uwe

190 S1 p.
artikel
32 Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome Laurent, Claire

190 S1 p.
artikel
33 Cutaneous relapses location in diffuse large B-cell lymphoma leg type after immunochemotherapy Pham-Ledard, Anne

190 S1 p.
artikel
34 Depicting a network of PKCθ effectors and their roles in the biology of CTCL cells Merino, Maria

190 S1 p.
artikel
35 Detection of circulating tumor DNA in liquid biopsies of patients with primary cutaneous diffuse large B-cell lymphoma, leg type Schrader, Anne

190 S1 p.
artikel
36 Diagnostic and prognostic significance of bone marrow biopsies for cutaneous T-cell lymphoma Weiner, David

190 S1 p.
artikel
37 Diagnostic outcomes and treatment modalities in patients with mycosis fungoides in west Sweden: a retrospective register-based study Wojewoda, Karolina

190 S1 p.
artikel
38 Differentiating lymphocytic hypereosinophilic syndrome from Sézary syndrome using transcriptomic analysis Pierog, Olivia

190 S1 p.
artikel
39 Editorial Board
190 S1 p.
artikel
40 Efficacy and safety of methotrexate in the treatment of mycosis fungoides: results from a multicenter study Panou, Evdoxia

190 S1 p.
artikel
41 Efficacy and tolerability of mogamulizumab in patients with mycosis fungoides or Sézary syndrome: retrospective and real-world data from centres of the French Study Group of Cutaneous Lymphoma Beylot-Barry, Marie

190 S1 p.
artikel
42 Elucidating genetic factors of cutaneous T-cell lymphoma staging and disease severity through machine learning Schreidah, Celine M.

190 S1 p.
artikel
43 Epidemiology of cutaneous T-cell lymphomas in Italy: data analysis from the Marche multidisciplinary team (MDT) register and Italian Cutaneous Lymphoma Study Group (ICLSG) open study Morsia, Erika

190 S1 p.
artikel
44 Evaluating the impact of a novel multidisciplinary mycosis fungoides cutaneous T-cell lymphoma clinic day on patient care Heath, Harry

190 S1 p.
artikel
45 Examining the long-term effects of educational intervention on illness perception in cutaneous T-cell lymphoma patients: a comparative analysis of gender, race, and age subgroups Munjal, Ananya

190 S1 p.
artikel
46 Ex vivo harmonic generation microscopy assessment in cutaneous T-cell lymphomas diagnosis Pavlova, Olesya

190 S1 p.
artikel
47 Genomic abnormalities involving class I HLA are common in advanced cutaneous T-cell lymphoma Kwang, Alexa

190 S1 p.
artikel
48 Genomic profiling of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder and angioimmunoblastic T-cell lymphoma Rodríguez, Marta

190 S1 p.
artikel
49 Haemophagocytic lymphohistiocytosis in a patient with stage IVA2 Sézary syndrome Thomas, Bjorn

190 S1 p.
artikel
50 Health-related quality of life assessed over time in the PROCLIPI study Molloy, Kevin

190 S1 p.
artikel
51 Health-related quality of life (HRQL) in cutaneous T-cell lymphoma: burden of disease and patient characteristics from a post-hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome Romero, Pablo

190 S1 p.
artikel
52 HLA I shields tumor lymphocytes from NK cell-mediated elimination in the skin Chang, Yun-Tsan

190 S1 p.
artikel
53 Immune cell profiling and regulatory proteins in MF lesions Vetsika, Eleni-Kyriaki

190 S1 p.
artikel
54 Inhibition of XPO1 with Selinexor (KPT-330) triggers apoptosis in cutaneous T-cell lymphoma (CTCL) by activating the p53-p21 and p27 pathways Chakravarti, Nitin

190 S1 p.
artikel
55 Insights from the 2020 Lymphoma Coalition Global Patient Survey on Lymphomas and CLL: the burden of fatigue Beatty, Paula

190 S1 p.
artikel
56 Interstitial fluid immunophenotyping of early-stage mycosis fungoides patients after chlormethine treatment Wind, Selinde

190 S1 p.
artikel
57 ISCL/USCLC/EORTC guidelines for the diagnosis, staging, and treatment of pediatric mycosis fungoides Hodak, Emilia

190 S1 p.
artikel
58 Is there microbial dysbiosis in CTCL? A pilot study Peterknecht, Elizabeth

190 S1 p.
artikel
59 KIR3DL2 also represents a novel therapeutic target in non-cutaneous aggressive systemic peripheral T-cell lymphomas Ortonne, Nicolas

190 S1 p.
artikel
60 Lacutamab in patients with mycosis fungoides: efficacy results according to updated lymph node classification in the TELLOMAK study Bagot, Martine

190 S1 p.
artikel
61 Leveraging deep learning to resolve skin lymphoma characteristics through highly multiplexed protein fluorescent imaging Prompsy, Pacome

190 S1 p.
artikel
62 Liquid biopsy assessment in primary cutaneous diffuse large B-Cell lymphoma- leg type Pham-Ledard, Anne

190 S1 p.
artikel
63 Lymphomatoid papulosis in paediatric population: results of a multicentre retrospective cohort study Blanchard, Maël

190 S1 p.
artikel
64 Modulation of immune cell polarization and PD-L1 expression by MF fibroblast exosomes: potential implications for immunotherapy in MF Moyal, Lilach

190 S1 p.
artikel
65 Mogamulizumab-induced colitis Blanchard, Maël

190 S1 p.
artikel
66 Mogamulizumab in patients with mycosis fungoides or Sézary syndrome: interim analysis of the German non-interventional MINT study Assaf, Chalid

190 S1 p.
artikel
67 Molecular identity revealed by NanoString analysis between tumoral erythroderma and inflammatory erythroderma Rodríguez, Marta

190 S1 p.
artikel
68 Multimodal therapy with bexarotene and extracorporeal photopheresis for T-cell cutaneous lymphomas: real-life experiences in Argentina Baquero Rey, Jenny Andrea

190 S1 p.
artikel
69 Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma Tsai, Yi-Chien

190 S1 p.
artikel
70 Non-invasive digital disease severity scoring compared to CAILS in early-stage mycosis fungoides Wind, Selinde

190 S1 p.
artikel
71 Non-myeloablative allogeneic stem cell transplantation using TSEBT, TLI and ATG for mycosis fungoides and Sézary syndrome: results from a large single centre cohort Thomas, Bjorn

190 S1 p.
artikel
72 Oncogenic drivers in NF-kappaB pathway-related elements provide candidate targets for future targeted therapies in Sézary syndrome Espinosa, Lluís

190 S1 p.
artikel
73 One-year assessment of consultations at the Dutch national referral and expertise center for cutaneous lymphomas Doeleman, Thom

190 S1 p.
artikel
74 Primary anaplastic large cell lymphoma in children and adolescents: case reports and literature review Barzilai, Aviv

190 S1 p.
artikel
75 Primary cutaneous CD4-positive small/medium pleomorphic lymphoproliferative disease: a retrospective analysis of 15 patients Patel, Nikesh

190 S1 p.
artikel
76 Primary cutaneous epidermotropic, cytotoxic, ALK+ T-cell lymphoma: observation of a novel case and review of the literature point at a discrete pattern of disease, with response to target therapy Croci, Giorgio Alberto

190 S1 p.
artikel
77 Primary cutaneous follicle center lymphoma with secondary systemic evolution Li, Andy

190 S1 p.
artikel
78 Prognostic factors in mycosis fungoides and Sézary syndrome: results from the PROCLIPI study Scarisbrick, Julia

190 S1 p.
artikel
79 Progressive peripheral polyneuropathy in a patient with Sézary syndrome Pappa, Vasiliki

190 S1 p.
artikel
80 Quality of life in cutaneous lymphoma varies by lymphoma type Lawrance, Nicholas

190 S1 p.
artikel
81 Racial disparities in mycosis fungoides/Sézary syndrome: an observational study of 296 patients Myskowski, Patricia

190 S1 p.
artikel
82 Real-world effectiveness of mogamulizumab in patients with Sézary syndrome or mycosis fungoides in Spain and Portugal: The MIBERIC study Romero, Pablo Ortiz

190 S1 p.
artikel
83 Real world evidence: assessing the clinical efficacy of mogamulizumab in mycosis fungoides and Sézary syndrome using time to next treatment Scarisbrick, Julia

190 S1 p.
artikel
84 Real-world outcomes and tolerability of mogamulizumab monotherapy and multimodality therapy for cutaneous T-cell lymphoma: results from a multicenter retrospective cohort study Weiner, David

190 S1 p.
artikel
85 RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome Stadler, Rudolf

190 S1 p.
artikel
86 Re-treatment approaches in patients with cutaneous-T-cell lymphoma: a real-life experience Roccuzzo, Gabriele

190 S1 p.
artikel
87 Role of total skin electron beam radiotherapy at relapse after allogeneic transplant in mycosis fungoides and Sézary syndrome Simontacchi, Gabriele

190 S1 p.
artikel
88 Sensitivity to brentuximab vedotin depends on CD30-expression levels in different subtypes of cutaneous T-cell lymphoma cell lines Hofer, Vivian

190 S1 p.
artikel
89 Single-cell RNA sequencing characterization of primary cutaneous B-cell lymphomas with their systemic counterparts Griss, Johanns

190 S1 p.
artikel
90 Single-cell RNA sequencing reveals crosstalk between T cells and endothelial cells in intravascular T-cell lymphoma Traidl, Stephan

190 S1 p.
artikel
91 Single-cell spatial immune landscapes of cutaneous T cell lymphomas (CTCL) Merkus, Veerle

190 S1 p.
artikel
92 Single-center experience with superficial radiation therapy of cutaneous lymphomas Szakonyi, Jozsef Agoston

190 S1 p.
artikel
93 Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor Brauner, Hanna

190 S1 p.
artikel
94 Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients Stammler, Romain

190 S1 p.
artikel
95 SNP rs10748643 within the promoter region of ENTPD1 (the gene encoding CD39) has no prognostic value in Sézary patients Luo, Yixin

190 S1 p.
artikel
96 Standard brentuximab vedotin schedule vs early discontinuation on clinician’s decision in patients with CTCL: a multicenter, retrospective study from the FIL Cutaneous Lymphomas Task Force Grandi, Vieri

190 S1 p.
artikel
97 Sustained complete remission in Sézary syndrome using extracorporeal photopheresis: a multicentric case series Cankaya, Rohat

190 S1 p.
artikel
98 Table of Contents
190 S1 p.
artikel
99 T cell receptor beta constant 1 as a potential marker to better assess T cell clonality in skin samples Iselin, Christoph

190 S1 p.
artikel
100 T-cell receptor clonality analyses using nanopore sequencing for cutaneous T-cell lymphoma Cieslak, Cassandra

190 S1 p.
artikel
101 Technical alignment of standardized flow cytometry procedures among Cutaneous Lymphoma Working Groups (CLWGs) and EuroFlow centers: update on a Multicenter Study de Bie, Fenna

190 S1 p.
artikel
102 The impact of advanced-stage cutaneous T-cell lymphoma on quality of life: a qualitative study Ottevanger, Rosanne

190 S1 p.
artikel
103 The impact of COVID-19 on anxiety, depression, and delays in care for patients with mycosis fungoides Munjal, Ananya

190 S1 p.
artikel
104 The overlap of skin and blood T-cell clones in early-stage mycosis fungoides Nikabakht, Neda

190 S1 p.
artikel
105 The spectrum of angioimmunoblastic T-cell lymphoma cutaneous lesions: clinical, pathological and molecular analysis De La Pinta, Francisco Javier Diaz

190 S1 p.
artikel
106 The validation of T-cell receptor constant beta-1 chain (TRBC1) in cutaneous T-cell lymphoma Pierog, Olivia

190 S1 p.
artikel
107 The value of digital PCR-based quantification of DNA methylation biomarkers in diagnostic challenging early Sézary syndrome patients Zoutman, Willem

190 S1 p.
artikel
108 Time to next treatment in primary cutaneous B cell lymphoma: experience on 98 patients Cankaya, Rohat

190 S1 p.
artikel
109 Title page
190 S1 p.
artikel
110 Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome Lazaridou, Ingrid

190 S1 p.
artikel
111 Translational data from a multicenter phase II study on dimethyl fumarate treatment in relapsed and refractory cutaneous T cell lymphoma Melchers, Susanne

190 S1 p.
artikel
112 Treatment of refractory cutaneous B-cell lymphoid hyperplasia with intralesional rituximab Laube, Simone

190 S1 p.
artikel
113 Treatment of relapsed/refractory, and advanced stage of mycosis fungoides with brentuximab vedotin (BV): an experience from Kuwait Hamed, Rasha

190 S1 p.
artikel
114 Treatment trends in CTCL: an update from a tertiary referral center in Italy Roccuzzo, Gabriele

190 S1 p.
artikel
115 Tumor necrosis factor receptor type 2 (TNFR2) may represent an alternative therapeutic target in Sézary syndrome and mycosis fungoides Beldi-Ferchiou, Asma

190 S1 p.
artikel
116 Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events Nikabakht, Neda

190 S1 p.
artikel
117 What we have learnt about the treatment of advanced stage MF from the PROCLIPI study Kim, Youn H.

190 S1 p.
artikel
118 Which parameters to use in flow cytometry in the diagnosis and follow up of mycosis fungoides and Sézary syndrome: a prospective study Kleiner, Pit Leonard

190 S1 p.
artikel
                             118 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland